What is the likely diagnosis for a 52-year-old female with a golf ball-sized, firm, slightly movable lump on the lateral side of her right abdomen near the liver, no weight loss, normal bowel and urinary habits, and a family history of ovarian (cancer of the ovaries) and prostate (gland) cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis and Immediate Management

This golf ball-sized, firm, slightly movable lateral abdominal mass in a 52-year-old woman with a family history of ovarian cancer requires urgent imaging with ultrasound followed by contrast-enhanced MRI or CT, and referral to a gynecologic oncologist if an adnexal mass is confirmed. The location near the liver on the lateral right abdomen could represent an ovarian/adnexal mass, hepatic lesion, or soft tissue tumor, and given her age, family history, and mass characteristics, malignancy must be excluded promptly.

Most Likely Diagnostic Considerations

Adnexal/Ovarian Mass (Primary Concern)

  • A pelvic/adnexal mass can extend into the lateral abdomen and present as a palpable mass in this location, particularly if it is large or pedunculated 1
  • The firm, slightly movable characteristics are consistent with either benign or malignant ovarian pathology 1
  • Her age (52 years, perimenopausal/postmenopausal) and family history of ovarian cancer place her at elevated risk for ovarian malignancy 1
  • Ovarian cancer is most prevalent in women in their sixth and seventh decades, with median age at diagnosis of 63 years 1

Hepatic Lesion

  • The proximity to the liver raises consideration of a hepatic mass, though these are typically less mobile 1
  • Hepatic adenomas, hemangiomas, or metastatic lesions could present in this location 1

Soft Tissue Mass

  • A soft tissue tumor (lipoma, fibroma, or sarcoma) arising from the abdominal wall or retroperitoneum could present with these characteristics 2
  • The slightly movable nature and firm consistency are consistent with various soft tissue pathologies 2

Immediate Diagnostic Workup

Initial Imaging

  • Obtain pelvic and abdominal ultrasound immediately as the first-line imaging modality 1
  • Ultrasound should include both transabdominal and transvaginal approaches to fully evaluate for adnexal pathology 1
  • Color or power Doppler should be included to assess vascularity and differentiate solid from cystic components 1

Advanced Imaging

  • If the mass is indeterminate on ultrasound, proceed with contrast-enhanced MRI of the pelvis and abdomen, which has superior soft-tissue discrimination and 91% accuracy for distinguishing benign from malignant masses 1
  • CT with contrast is an alternative if MRI is not feasible, though it has lower specificity than MRI for adnexal mass characterization 1
  • Chest imaging should be obtained to evaluate for metastatic disease if malignancy is suspected 1

Laboratory Evaluation

  • Measure CA-125 immediately, as it is elevated in approximately 85% of advanced ovarian cancers 1, 3, 4
  • Obtain complete blood count (CBC) and comprehensive metabolic panel including liver function tests 1, 3
  • Consider additional tumor markers based on imaging findings: CEA (if mucinous histology suspected), LDH (for germ cell tumors), inhibin (for granulosa cell tumors) 3
  • A CA-125/CEA ratio >25 favors ovarian origin over gastrointestinal origin 4

Critical Referral Criteria

Gynecologic Oncology Referral

  • Refer immediately to a gynecologic oncologist if imaging reveals an adnexal mass with any concerning features 1, 5
  • Referral is mandatory for O-RADS 4 (intermediate risk) or O-RADS 5 (high risk) lesions 5
  • Elevated CA-125 in a postmenopausal woman with a pelvic mass, or CA-125 >200 units/mL in a premenopausal woman, warrants gynecologic oncology referral 5
  • Published data demonstrate that primary assessment and surgical debulking by a gynecologic oncologist result in a survival advantage 1

Features Suggesting Malignancy on Imaging

  • Solid components with enhancement 1
  • Enhancing mural nodules or papillary projections 1
  • Presence of ascites 1
  • Bilateral masses 1
  • Irregular borders or surface involvement 1

Common Pitfalls to Avoid

  • Do not rely solely on CA-125 for diagnosis, as it can be elevated in many benign conditions (endometriosis, fibroids, pelvic inflammatory disease) and may not be elevated in early-stage ovarian cancer 3
  • Do not assume a lateral abdominal mass is necessarily hepatic or abdominal wall in origin without excluding adnexal pathology, as large ovarian masses can extend superiorly 1
  • Do not delay imaging or referral based on the absence of constitutional symptoms, as early ovarian cancer often presents without weight loss or systemic symptoms 1
  • Avoid performing only transabdominal ultrasound without transvaginal imaging, as this may miss important adnexal pathology 1

Timeline for Action

  • Imaging should be obtained within 1-2 weeks given the family history and mass characteristics 1, 5
  • If imaging reveals concerning features, referral to gynecologic oncology should occur within 2 weeks 5
  • The 2-day duration of awareness is reassuring that this is not an acute process requiring emergency intervention, but the evaluation should not be delayed 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluating Soft-Tissue Lumps and Bumps.

Missouri medicine, 2017

Guideline

Laboratory Workup for a Potential Pelvic Mass

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Distinguishing Ovarian and Uterine Primary Malignancies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gynecologic Referral Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the treatment options for a lump?
What is the appropriate assessment for a lump at the belt level?
What is the management for a 19-year-old female with a diagnosed fibroadenoma (benign breast tumor) of the breast, presenting as a 3 x 2 cm rounded, firm, mobile mass on ultrasound (US) and confirmed by core needle biopsy (CNB)?
What is the management for a 19-year-old female with a 3 x 2 cm fibroadenoma (ultrasound and core needle biopsy confirmed)?
What is the management of a 19-year-old female with a 3 x 2 cm rounded, firm, mobile breast mass diagnosed as fibroadenoma on ultrasound (US) and core needle biopsy (CNB)?
What anxiolytics, apart from benzodiazepines, can be used in a patient with silent reflux (laryngopharyngeal reflux) without exacerbating the condition?
What are the initial management steps for a patient presenting with acute stroke according to the American Heart Association (AHA) 2026 guidelines?
What is the threshold for exchange transfusion in a neonate with severe jaundice based on the National Institute for Health and Care Excellence (NICE) guideline, with total serum bilirubin levels in umol/L?
What oral diabetic medication is suitable for a patient with diabetes mellitus (DM), heart disease, and hyponatremia?
What is the optimal management approach for a patient with Small Bowel Obstruction (SBO), considering their medical history and demographic characteristics?
What is the best management approach for a patient with a recent history of neurosurgery for a brain tumor who now presents with a massive pulmonary embolism (PE)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.